Cheryl Macdiarmid

Cheryl is currently the Senior Vice President and Head of Global Commercial Strategy for ViiV Healthcare, the joint venture between GSK, Pfizer and Shionogi which specialises in the development of therapies for HIV. She has more than 25 years’ experience in commercial roles within the global pharmaceuticals sector. Cheryl has significant senior leadership experience within GSK, initially in Canada and then in the US where she led the Respiratory Business Unit and associated US operations.